AAM
BNTX icon

Advisors Asset Management’s BioNTech BNTX Stock Holding History

Advisors Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-557
Closed -$50.7K – 1479
2025
Q1 		$50.7K Sell
557
-289
-34% -$32.4K ﹤0.01% 1283
2024
Q4 		$96.4K Sell
846
-890
-51% -$102K ﹤0.01% 1229
2024
Q3 		$206K Sell
1,736
-163
-9% -$15K ﹤0.01% 1101
2024
Q2 		$153K Sell
1,899
-1,369
-42% -$125K ﹤0.01% 1153
2024
Q1 		$301K Sell
3,268
-590
-15% -$56.6K 0.01% 1044
2023
Q4 		$407K Sell
3,858
-3,548
-48% -$358K 0.01% 954
2023
Q3 		$805K Buy
7,406
+32
+0.4% +$3.54K 0.02% 773
2023
Q2 		$796K Sell
7,374
-3,306
-31% -$372K 0.02% 820
2023
Q1 		$1.33M Buy
10,680
+533
+5% +$73.2K 0.03% 655
2022
Q4 		$1.52M Sell
10,147
-10,342
-50% -$1.59M 0.03% 590
2022
Q3 		$2.76M Sell
20,489
-766
-4% -$117K 0.06% 393
2022
Q2 		$3.17M Buy
21,255
+1,274
+6% +$195K 0.06% 358
2022
Q1 		$3.41M Buy
19,981
+1,582
+9% +$266K 0.05% 398
2021
Q4 		$4.74M Buy
18,399
+1,644
+10% +$450K 0.07% 313
2021
Q3 		$4.57M Buy
16,755
+2,235
+15% +$710K 0.07% 286
2021
Q2 		$3.25M Buy
14,520
+2,934
+25% +$553K 0.05% 411
2021
Q1 		$1.26M Buy
11,586
+6,225
+116% +$661K 0.02% 747
2020
Q4 		$437K Buy
+5,361
New +$526K 0.01% 1009

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Advisors Asset Management's BNTX Position: Q2 2025 in Review

Advisors Asset Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 557 shares — an estimated $50.7K sold.

Advisors Asset Management first reported a position in BNTX in Q4 2020 and held it in 18 quarters. The position peaked at $4.74M in Q4 2021. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Advisors Asset Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Advisors Asset Management sold 557 BioNTech shares in Q2 2025, an estimated $50.7K.
  • Advisors Asset Management first reported a position in BioNTech in Q4 2020 and held it in 18 quarters.
  • Advisors Asset Management's BioNTech position peaked at $4.74M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Advisors Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.